BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31421101)

  • 41. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Sekihara K; Hishida T; Yoshida J; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Matsuzawa R; Aokage K; Goto K; Tsuboi M
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):522-528. PubMed ID: 28482033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection.
    Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY
    Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [What can thoracic surgery accomplish in recurrent/second carcinoma of non-small-cell bronchial carcinoma?].
    Wex P; Utta E; Haas V
    Kongressbd Dtsch Ges Chir Kongr; 2002; 119():785-91. PubMed ID: 12704929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis.
    Saito Y; Kawai Y; Takahashi N; Ikeya T; Murai K; Kawabata Y; Hoshi E
    Ann Thorac Surg; 2011 Nov; 92(5):1812-7. PubMed ID: 21944440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of gross tumor volume for definitive radiation therapy in patients with locoregionally recurrent non-small-cell lung cancer after surgical resection.
    Lee NK; Moon SH; Kim TH; Han JY; Yun T; Kim HT; Lee HS; Kim MS; Lee JM; Cho KH; Lee JS
    Clin Lung Cancer; 2013 Jul; 14(4):399-406. PubMed ID: 23276823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.
    Yang CJ; Kumar A; Klapper JA; Hartwig MG; Tong BC; Harpole DH; Berry MF; D'Amico TA
    Ann Surg; 2019 Jan; 269(1):163-171. PubMed ID: 28799982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer.
    Brown LM; Louie BE; Jackson N; Farivar AS; Aye RW; Vallières E
    Ann Thorac Surg; 2016 Oct; 102(4):1110-8. PubMed ID: 27350237
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
    Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
    Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
    Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-recurrence survival analysis of stage I non-small-cell lung cancer.
    Lee K; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Han J
    Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):623-629. PubMed ID: 29058973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Results of long-term follow-up of patients with completely resected non-small cell lung cancer.
    Endo C; Sakurada A; Notsuda H; Noda M; Hoshikawa Y; Okada Y; Kondo T
    Ann Thorac Surg; 2012 Apr; 93(4):1061-8. PubMed ID: 22386090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
    Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
    Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy.
    Lee PC; Kamel M; Nasar A; Ghaly G; Port JL; Paul S; Stiles BM; Andrews WG; Altorki NK
    Ann Thorac Surg; 2016 Mar; 101(3):1116-22. PubMed ID: 26654728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of nuclear factor of activated T-cells 5 expression in non-small cell lung cancer patients who underwent surgical resection.
    Cho HJ; Yun HJ; Yang HC; Kim SJ; Kang SK; Che C; Lee SD; Kang MW
    J Surg Res; 2018 Jun; 226():40-47. PubMed ID: 29661287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The management of second primary lung cancers. A single centre experience in 15 years.
    Aziz TM; Saad RA; Glasser J; Jilaihawi AN; Prakash D
    Eur J Cardiothorac Surg; 2002 Mar; 21(3):527-33. PubMed ID: 11888775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
    Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
    J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical outcomes and prognostic factors for surgically resected second primary lung cancer.
    Bae MK; Byun CS; Lee CY; Lee JG; Park IK; Kim DJ; Chung KY
    Thorac Cardiovasc Surg; 2012 Dec; 60(8):525-32. PubMed ID: 22411753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.